Lilly Insulin Glargine Versus Lantus® in Insulin-Naïve and Insulin-Treated Adults with Type 2 Diabetes: A Randomized, Controlled Trial (ELEMENT 5).
Robyn K PollomLiza L IlagLyndon B LacayaTina M MorwickRamón Ortiz CarrasquilloPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2019)
Eli Lilly and Company and Boehringer Ingelheim. Plain language summary available for this article.